Planning to import medicinal cannabis products for supply to Australian patients.

( ) has been granted a licence to import and export cannabis genetics and medicinal cannabis products by the Office of Drug Control, Australian Department of Health.

As a holder of this licence, the company can now apply for a permit to export raw cannabis material and cannabis oil for analytical testing.

Cann intends to utilise the analytical services of Anandia Laboratories in Canada to complement the capabilities available to the company in Australia.

The licence also allows Cann to apply for a permit to import cannabis genetics and medicinal cannabis products from legal international sources.

Cann is working closely with Canadian companies and Anandia Laboratories to identify suitable genetics and medicinal cannabis products for inclusion in an import permit application.

The company is aiming to submit the application soon to facilitate the process of obtaining export approvals with Health Canada.

The granting of the new licence is an important milestone for Cann in building a genetic database of locally and internationally sourced cannabis strains for cultivation under its medicinal cannabis licence.

Similarly, the import/export licence is a key step in the company’s plans to import medicinal cannabis products for supply to Australian patients to complement locally manufactured products.